Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study

BACKGROUND: The use of metformin after acute myocardial infarction (AMI) has been associated with reduced mortality in people with type 2 diabetes mellitus (T2DM). However, it is not known if it is acutely cardioprotective in patients taking metformin at the time of AMI. We compared patient outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Bromage, Daniel I., Godec, Tom R., Pujades-Rodriguez, Mar, Gonzalez-Izquierdo, Arturo, Denaxas, S., Hemingway, Harry, Yellon, Derek M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900858/
https://www.ncbi.nlm.nih.gov/pubmed/31815634
http://dx.doi.org/10.1186/s12933-019-0972-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900858/
https://www.ncbi.nlm.nih.gov/pubmed/31815634
http://dx.doi.org/10.1186/s12933-019-0972-4

Ejemplares similares